These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38057821)

  • 1. Prognosis prediction based on methionine metabolism genes signature in gliomas.
    Zhou S; Zhao X; Zhang S; Tian X; Wang X; Mu Y; Li F; Zhao AZ; Zhao Z
    BMC Med Genomics; 2023 Dec; 16(1):317. PubMed ID: 38057821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
    Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
    Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a copper metabolism-related gene signature for predicting prognosis and immune response in glioma.
    Li L; Leng W; Chen J; Li S; Lei B; Zhang H; Zhao H
    Cancer Med; 2023 Apr; 12(8):10123-10137. PubMed ID: 36856182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
    Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
    Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
    [No Abstract]   [Full Text] [Related]  

  • 16. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
    Huang Q; Li J; Mo L; Zhao Y
    World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.